SCHEMBL2349643

SCHEMBL2349643

N#CC(=O)O.[Fe]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5498299 1.00
Water SCHEMBL8848944 0.95
SCHEMBL37136 0.95
Hydrochloric Acid SCHEMBL6643669 0.91
SCHEMBL10339487 0.91
SCHEMBL23218025 0.91
Water SCHEMBL8502324 0.91
SCHEMBL3269957 0.91
Ammonia Solution, Strong SCHEMBL21838765 0.91
SCHEMBL8895617 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112604486-A High-sulfur-capacity double-alkali system compound desulfurizer 中石化南京化工研究院有限公司 2021-04-06 CN claimed
US-20170157174-A1 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS ISTITUTO SUPERIORE DI SANITA (IT) 2017-06-08 US claimed
EP-2349245-B1 TREATMENT OF LATENT HIV-1 INFECTIONS USING AURANOFIN OR ARSENIC TRIOXIDE Istituto Superiore di Sanità (IT) 2016-08-03 EP claimed
US-20150024065-A1 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS ISTITUTO SUPERIORE DI SANITA (IT) 2015-01-22 US claimed
US-8785493-B2 Treatment of retroviral reservoirs exploiting oxidative stress ISTITUTO SUPERIORE DI SANITA (IT) 2014-07-22 US claimed
US-20110305774-A1 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS ISTITUTO SUPERIORE DI SANITA (IT) 2011-12-15 US claimed
EP-2349245-A2 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS Istituto Superiore di Sanità (IT) 2011-08-03 EP claimed
WO-2010049182-A2 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS ISTITUTO SUPERIORE DI SANITÁ (IT) 2010-05-06 WO claimed
US-4859436-A H2 S removal process and composition SHELL OIL COMPANY (US) 1989-08-22 US claimed
JP-63141584-A None JP disclosed
EP-4119548-A1 METHOD FOR THE PRODUCTION OF ALKYLENE OXIDES Covestro Deutschland AG (DE) 2023-01-18 EP disclosed
CN-112604486-A High-sulfur-capacity double-alkali system compound desulfurizer 中石化南京化工研究院有限公司 2021-04-06 CN disclosed
US-20170157174-A1 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS ISTITUTO SUPERIORE DI SANITA (IT) 2017-06-08 US disclosed
EP-2349245-B1 TREATMENT OF LATENT HIV-1 INFECTIONS USING AURANOFIN OR ARSENIC TRIOXIDE Istituto Superiore di Sanità (IT) 2016-08-03 EP disclosed
US-20050106657-A1 Method of producing lycopene through the fermentation of selected strains of blackeslea trispora, formulations and uses of the lycopene thus obtained DSM IP ASSETS B.V. (NL) 2005-05-19 US disclosed
US-20040214998-A1 Purified Cys Moiety for Iron Reductase, and Method for Obtaining and Using Same OLISA, Mr. N. (US) 2004-10-28 US disclosed
EP-1471151-A1 IMPROVED METHOD OF PRODUCING LYCOPENE THROUGH THE FERMENTATION OF SELECTED STRAINS OF BLAKESLEA TRISPORA, FORMULATIONS AND USES OF THE LYCOPENE THUS OBTAINED Vitatene, S.A. (ES) 2004-10-27 EP disclosed
US-20030077693-A1 Use of p97 and iron binding proteins as diagnostic and therapeutic agents UNIVERSITY OF BRITISH COLUMBIA (CA) 2003-04-24 US disclosed
US-5981194-A DETERMINING OR MONITORING ALZHEIMER'S DISEASE IN PATIENTS SUSPECTED OF HAVING ALZHEIMER'S DISEASE; MEASURING THE CONCENTRATION OF PROTEIN MARKER IN SAMPLE AND COMPARE IT A CONTROL; MONITORING THERAPIES FOR ALZHEIMER'S DISEASE UNIVERSITY OF BRITISH COLUMBIA (CA) 1999-11-09 US disclosed
JP-S63141584-A MEDIUM FOR CELL CULTURE CHEMO SERO THERAPEUT RES INST 1988-06-14 JP disclosed